Get an alert when DUNAD THERAPEUTICS LTD. files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-04-15 (in 11mo)

Last made up 2026-04-01

Watchouts

2 items

Cash

£10M

-19.5% lowest in 4 filed years

Net assets

£10M

-15.7% vs 2023

Employees

28

+7.7% highest in 4 filed years

Profit before tax

-£13M

-23.2% lowest in 3 filed years

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

6-year trend · latest reflected 2024-12-31

Metric Trend 2020-08-312021-08-312022-08-312022-12-312023-12-312024-12-31
Turnover £7,483,017£9,221,243£5,214,555
Operating profit £420,982-£10,884,441-£13,259,982
Profit before tax £451,637-£10,463,204-£12,887,249
Net profit £894,148-£673,575-£9,479,249-£12,043,109
Cash £28,054,292£25,254,899£12,647,994£10,181,189
Total assets less current liabilities £11,964,851£10,087,693
Net assets £11,964,851£10,087,693
Equity £0£521,410£22,994,446£11,964,851£10,087,693
Average employees 6112628
Wages £601,679£5,232,229£6,064,868
Directors' remuneration £898,969£736,760

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2020-08-312021-08-312022-08-312022-12-312023-12-312024-12-31
Operating margin 5.6%-118.0%
Net margin 11.9%-102.8%
Return on capital employed -91.0%-131.4%
Current ratio 3.30x5.70x
Interest cover -184482.05x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

Name history

Renamed 1 time since incorporation

  1. DUNAD THERAPEUTICS LTD. 2020-08-14 → present
  2. WARHEAD LTD 2020-04-02 → 2020-08-14

Audit & accounting basis

Accounting basis
FRS 102 §1A
Reporting scope
Consolidated group
Abridged
Yes — abridged accounts (limited disclosure)
Auditor
Moore Kingston Smith LLP
Audit opinion
Unqualified (clean)
Going concern
Material uncertainty disclosed

“We draw attention to note 1.3 to the financial statements which indicates that a material uncertainty relating to going concern exists due to the group and parent company's additional investor funding commitments being dependent on the continued success of the lead program. Whilst the directors are confident based on current and historic development performance and levels of investor funding, as stated in note 1.3, these events or conditions indicate that a material uncertainty exists that may cast significant doubt on the group and parent company's ability to continue as a going concern. Our opinion is not modified in respect of this matter.”

Group structure

  1. DUNAD THERAPEUTICS LTD. · parent
    1. Dunad Therapeutics US, Inc. 1% · USA · Research and experimental development on biotechnology
    2. 2740376 Ontario Inc. 1% · Canada · Holding company
    3. 2752591 Ontario Inc. 1% · Canada · Holding company
    4. 2692372 Ontario Inc. 1% · Canada · Holding company

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

7 active · 6 resigned

Name Role Appointed Born Nationality
OAKWOOD CORPORATE SECRETARY LIMITED Corporate Secretary 2023-07-14
BONNEY, Michael Weston Director 2023-04-14 Aug 1958 American
EDWARDES JONES, Lucy Charlotte Director 2024-08-14 Oct 1992 British
GUPTA, Varun Kumar, Dr Director 2024-03-28 Aug 1986 Indian
HUANG, Pearl S., Dr Director 2022-05-04 May 1957 American
ROPER, Elizabeth Ann, Dr Director 2020-04-22 Jul 1974 Irish
SLOTBOOM, Oskar Director 2021-04-21 Apr 1975 Dutch
Show 6 resigned officers
Name Role Appointed Resigned
DIMITROPOULOS, Chris Director 2022-07-16 2024-08-14
GUNNING, Patrick Thomas, Professor Director 2022-10-12 2024-05-31
GUNNING, Patrick Thomas, Professor Director 2021-04-21 2022-07-16
HODITS, Regina Director 2022-07-16 2024-03-28
KRASKOUSKAYA, Dziyana Director 2020-04-20 2022-10-12
MCMINN, Vanessa Lea Director 2020-04-02 2020-04-20

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Epidarex Capital Iii Uk, Lp Corporate entity Shares 25–50% 2020-04-22 Ceased 2024-08-14
Dziyana Kraskouskaya Individual voting-rights-25-to-50-percent-as-trust 2020-04-20 Ceased 2024-08-14
Ms Vanessa Lea Mcminn Individual Shares 75–100%, Voting 75–100%, Appoints directors 2020-04-02 Ceased 2020-04-20

Filing timeline

Last 20 of 101 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2025-08-22 MA Memorandum articles
  • 2025-08-22 RESOLUTIONS Resolution
Date Type Category Description
2026-04-23 CS01 confirmation-statement Confirmation statement with updates PDF
2026-04-23 RP01AP01 officers Replacement filing of director appointment with name PDF
2026-04-21 RP01AP01 officers Replacement filing of director appointment with name PDF
2026-02-16 SH01 capital Capital allotment shares PDF
2025-12-09 SH01 capital Capital allotment shares PDF
2025-10-10 SH01 capital Capital allotment shares PDF
2025-09-23 SH01 capital Capital allotment shares PDF
2025-09-22 AA accounts Accounts with accounts type group PDF
2025-08-28 SH10 capital Capital variation of rights attached to shares
2025-08-27 SH01 capital Capital allotment shares PDF
2025-08-22 MA incorporation Memorandum articles
2025-08-22 RESOLUTIONS resolution Resolution
2025-05-09 SH01 capital Capital allotment shares PDF
2025-04-10 CS01 confirmation-statement Confirmation statement with updates PDF
2025-04-10 CH01 officers Change person director company with change date PDF
2025-01-23 SH01 capital Capital allotment shares PDF
2024-12-23 SH01 capital Capital allotment shares PDF
2024-11-18 SH01 capital Capital allotment shares PDF
2024-11-13 AA accounts Accounts with accounts type group PDF
2024-08-30 RP04AP01 officers Second filing of director appointment with name PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
13

last 12 months

Capital events
10

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page